Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $7.45B | $6.11B | +21.98% |
Cost of Revenue | $3.2B | $1.72B | +86.05% |
Operating Income | $991M | $1.92B | -48.41% |
Net Income | $-113M | $2.84B | -103.98% |
EPS (Basic) | $-0.21 | $5.32 | -103.95% |
EPS (Diluted) | $-0.21 | $5.28 | -103.98% |
SG&A Expense | $1.81B | $1.26B | +43.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $92.98B | $88.72B | +4.80% |
Current Assets | $28.03B | $44.7B | -37.30% |
Current Liabilities | $19.71B | $14.21B | +38.68% |
Stockholders' Equity | $5.02B | $5.35B | -6.10% |
Cash & Equivalents | $9.71B | $31.56B | -69.24% |
Long-Term Debt | $64.02B | $61.59B | +3.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $689M | $1.06B | -35.24% |
Investing Cash Flow | $-217M | $1.36B | -115.98% |
Financing Cash Flow | $-1.71B | $21.51B | -107.94% |
D&A | $1.4B | $900M | +55.44% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 13.3% | 31.5% | -18.16% |
Net Margin | -1.5% | — | — |
ROE | -2.3% | — | — |
ROA | -0.1% | — | — |
Current Ratio | $1.422 | — | — |
Other companies in Biotechnology